The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Epigenetics-Global Market Insights and Sales Trends 2024

Epigenetics-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1849744

No of Pages : 112

Ask Your Query

Synopsis

Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the Others factors supporting market growth.

The global Epigenetics market size is expected to reach US$ 27650 million by 2029, growing at a CAGR of 17.1% from 2023 to 2029. The market is mainly driven by the significant applications of Epigenetics in various end use industries.

The expanding demands from the Academic & Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Contract Research Organizations (CROs), are propelling Epigenetics market. Enzymes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Kits & Assays segment is estimated at % CAGR for the next seven-year period.

Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epigenetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Epigenetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Epigenetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epigenetics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Epigenetics covered in this report include Thermo Fisher Scientific, Merck & Co., Zymo Research, Abcam, Qiagen, Illumina, Active Motif, Bio-Rad and New England Biolabs, etc.

The global Epigenetics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Thermo Fisher Scientific
  • Merck & Co.
  • Zymo Research
  • Abcam
  • Qiagen
  • Illumina
  • Active Motif
  • Bio-Rad
  • New England Biolabs
  • Agilent
  • Perkinelmer
  • Diagenode
  • Epizyme Inc.
  • CellCentric Ltd.
  • ValiRx plc
  • EpiGentek

Global Epigenetics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Epigenetics market, Segment by Type:

  • Enzymes
  • Kits & Assays
  • Instruments and Consumables
  • Reagents

Global Epigenetics market, by Application

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epigenetics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Epigenetics
1.1 Epigenetics Market Overview
1.1.1 Epigenetics Product Scope
1.1.2 Epigenetics Market Status and Outlook
1.2 Global Epigenetics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Epigenetics Market Size by Region (2018-2029)
1.4 Global Epigenetics Historic Market Size by Region (2018-2023)
1.5 Global Epigenetics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Epigenetics Market Size (2018-2029)
1.6.1 North America Epigenetics Market Size (2018-2029)
1.6.2 Europe Epigenetics Market Size (2018-2029)
1.6.3 Asia-Pacific Epigenetics Market Size (2018-2029)
1.6.4 Latin America Epigenetics Market Size (2018-2029)
1.6.5 Middle East & Africa Epigenetics Market Size (2018-2029)
2 Epigenetics Market by Type
2.1 Introduction
2.1.1 Enzymes
2.1.2 Kits & Assays
2.1.3 Instruments and Consumables
2.1.4 Reagents
2.2 Global Epigenetics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Epigenetics Historic Market Size by Type (2018-2023)
2.2.2 Global Epigenetics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Epigenetics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Epigenetics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Epigenetics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Epigenetics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Epigenetics Revenue Breakdown by Type (2018-2029)
3 Epigenetics Market Overview by Application
3.1 Introduction
3.1.1 Academic & Research Institutes
3.1.2 Pharmaceutical Companies
3.1.3 Biotechnology Companies
3.1.4 Contract Research Organizations (CROs)
3.1.5 Others
3.2 Global Epigenetics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Epigenetics Historic Market Size by Application (2018-2023)
3.2.2 Global Epigenetics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Epigenetics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Epigenetics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Epigenetics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Epigenetics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Epigenetics Revenue Breakdown by Application (2018-2029)
4 Epigenetics Competition Analysis by Players
4.1 Global Epigenetics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epigenetics as of 2022)
4.3 Date of Key Players Enter into Epigenetics Market
4.4 Global Top Players Epigenetics Headquarters and Area Served
4.5 Key Players Epigenetics Product Solution and Service
4.6 Competitive Status
4.6.1 Epigenetics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Epigenetics Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Epigenetics Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Merck & Co.
5.2.1 Merck & Co. Profile
5.2.2 Merck & Co. Main Business
5.2.3 Merck & Co. Epigenetics Products, Services and Solutions
5.2.4 Merck & Co. Epigenetics Revenue (US$ Million) & (2018-2023)
5.2.5 Merck & Co. Recent Developments
5.3 Zymo Research
5.3.1 Zymo Research Profile
5.3.2 Zymo Research Main Business
5.3.3 Zymo Research Epigenetics Products, Services and Solutions
5.3.4 Zymo Research Epigenetics Revenue (US$ Million) & (2018-2023)
5.3.5 Abcam Recent Developments
5.4 Abcam
5.4.1 Abcam Profile
5.4.2 Abcam Main Business
5.4.3 Abcam Epigenetics Products, Services and Solutions
5.4.4 Abcam Epigenetics Revenue (US$ Million) & (2018-2023)
5.4.5 Abcam Recent Developments
5.5 Qiagen
5.5.1 Qiagen Profile
5.5.2 Qiagen Main Business
5.5.3 Qiagen Epigenetics Products, Services and Solutions
5.5.4 Qiagen Epigenetics Revenue (US$ Million) & (2018-2023)
5.5.5 Qiagen Recent Developments
5.6 Illumina
5.6.1 Illumina Profile
5.6.2 Illumina Main Business
5.6.3 Illumina Epigenetics Products, Services and Solutions
5.6.4 Illumina Epigenetics Revenue (US$ Million) & (2018-2023)
5.6.5 Illumina Recent Developments
5.7 Active Motif
5.7.1 Active Motif Profile
5.7.2 Active Motif Main Business
5.7.3 Active Motif Epigenetics Products, Services and Solutions
5.7.4 Active Motif Epigenetics Revenue (US$ Million) & (2018-2023)
5.7.5 Active Motif Recent Developments
5.8 Bio-Rad
5.8.1 Bio-Rad Profile
5.8.2 Bio-Rad Main Business
5.8.3 Bio-Rad Epigenetics Products, Services and Solutions
5.8.4 Bio-Rad Epigenetics Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Profile
5.9.2 New England Biolabs Main Business
5.9.3 New England Biolabs Epigenetics Products, Services and Solutions
5.9.4 New England Biolabs Epigenetics Revenue (US$ Million) & (2018-2023)
5.9.5 New England Biolabs Recent Developments
5.10 Agilent
5.10.1 Agilent Profile
5.10.2 Agilent Main Business
5.10.3 Agilent Epigenetics Products, Services and Solutions
5.10.4 Agilent Epigenetics Revenue (US$ Million) & (2018-2023)
5.10.5 Agilent Recent Developments
5.11 Perkinelmer
5.11.1 Perkinelmer Profile
5.11.2 Perkinelmer Main Business
5.11.3 Perkinelmer Epigenetics Products, Services and Solutions
5.11.4 Perkinelmer Epigenetics Revenue (US$ Million) & (2018-2023)
5.11.5 Perkinelmer Recent Developments
5.12 Diagenode
5.12.1 Diagenode Profile
5.12.2 Diagenode Main Business
5.12.3 Diagenode Epigenetics Products, Services and Solutions
5.12.4 Diagenode Epigenetics Revenue (US$ Million) & (2018-2023)
5.12.5 Diagenode Recent Developments
5.13 Epizyme Inc.
5.13.1 Epizyme Inc. Profile
5.13.2 Epizyme Inc. Main Business
5.13.3 Epizyme Inc. Epigenetics Products, Services and Solutions
5.13.4 Epizyme Inc. Epigenetics Revenue (US$ Million) & (2018-2023)
5.13.5 Epizyme Inc. Recent Developments
5.14 CellCentric Ltd.
5.14.1 CellCentric Ltd. Profile
5.14.2 CellCentric Ltd. Main Business
5.14.3 CellCentric Ltd. Epigenetics Products, Services and Solutions
5.14.4 CellCentric Ltd. Epigenetics Revenue (US$ Million) & (2018-2023)
5.14.5 CellCentric Ltd. Recent Developments
5.15 ValiRx plc
5.15.1 ValiRx plc Profile
5.15.2 ValiRx plc Main Business
5.15.3 ValiRx plc Epigenetics Products, Services and Solutions
5.15.4 ValiRx plc Epigenetics Revenue (US$ Million) & (2018-2023)
5.15.5 ValiRx plc Recent Developments
5.16 EpiGentek
5.16.1 EpiGentek Profile
5.16.2 EpiGentek Main Business
5.16.3 EpiGentek Epigenetics Products, Services and Solutions
5.16.4 EpiGentek Epigenetics Revenue (US$ Million) & (2018-2023)
5.16.5 EpiGentek Recent Developments
6 North America
6.1 North America Epigenetics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Epigenetics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Epigenetics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Epigenetics Market Dynamics
11.1 Epigenetics Industry Trends
11.2 Epigenetics Market Drivers
11.3 Epigenetics Market Challenges
11.4 Epigenetics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock